Výsledky vyhledávání - Martin Lefkowitz
- Zobrazuji výsledky 1 - 20 z 85
- Přejít na další stránku
-
1
-
2
-
3
The Effects of Aldosterone Synthase Inhibition on Aldosterone and Cortisol in Patients With Hypertension: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Stud... Autor Karl Andersen, Daniel Hartman, Thomas Peppard, David Hermann, Peter Van Ess, Martin Lefkowitz, Angelo J. Trapani
Vydáno 2012Artigo -
4
A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation Autor J. Novick, Philip B. Miner, Richard A. Krause, Kathie Glebas, H Bliesath, Gregory Ligozio, P. Rüegg, Martin Lefkowitz
Vydáno 2002Artigo -
5
-
6
Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized contro... Autor Kenneth Jamerson, George L. Bakris, C. C. Wun, Björn Dahlöf, Martin Lefkowitz, S Manfreda, Bertram Pitt, Eric J. Velazquez, Michael A. Weber
Vydáno 2004Revisão -
7
-
8
Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension Autor Kazuomi Kario, Ningling Sun, Fu‐Tien Chiang, Ouppatham Supasyndh, Sang Hong Baek, Akiko Inubushi-Molessa, Ying Zhang, Hiromi Gotou, Martin Lefkowitz, Jack Zhang
Vydáno 2014Artigo -
9
-
10
Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial Autor Akshay S. Desai, Scott D. Solomon, Brian Claggett, John J.V. McMurray, Jean L. Rouleau, Karl Swedberg, Michael R. Zile, Martin Lefkowitz, Victor Shi, Milton Packer
Vydáno 2016Artigo -
11
-
12
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction Autor Muthiah Vaduganathan, Pardeep S. Jhund, Brian Claggett, Milton Packer, J Widimský, Petar Seferović, Adel R. Rizkala, Martin Lefkowitz, Victor Shi, John J.V. McMurray, Scott D. Solomon
Vydáno 2020Artigo -
13
Exceptional early blood pressure control rates: The ACCOMPLISH trial Autor Kenneth Jamerson, George L. Bakris, Björn Dahlöf, Bertram Pitt, Eric J. Velazquez, Jitendra Gupte, Martin Lefkowitz, Allen Hester, Victor Shi, Sverre E. Kjeldsen, William C. Cushman, Vasilios Papademetriou, Michael A. Weber, Kenneth Jamerson, George L. Bakris, Björn Dahlöf, Bertram Pitt, Eric J. Velazquez, Jitendra Gupte, Martin Lefkowitz, Allen Hester, Victor Shi, Sverre E. Kjeldsen, William C. Cushman, Vasilios Papademetriou, Michael A. Weber
Vydáno 2007Artigo -
14
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, <scp>LCZ696</scp>, in patients with heart failure with preserved e... Autor Pardeep S. Jhund, Brian Claggett, Milton Packer, Michael R. Zile, Adriaan A. Voors, Burkert Pieske, Martin Lefkowitz, Victor Shi, Toni Bransford, John J.V. McMurray, Scott D. Solomon
Vydáno 2014Artigo -
15
Baseline characteristics and treatment of patients in Prospective comparison of <scp>ARNI</scp> with <scp>ACEI</scp> to Determine Impact on Global Mortality and morbidity in Heart... Autor John J.V. McMurray, Milton Packer, Akshay S. Desai, Jianjian Gong, Martin Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor Shi, Scott D. Solomon, Karl Swedberg, Michael R. Zile
Vydáno 2014Artigo -
16
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin‐converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and... Autor John J.V. McMurray, Milton Packer, Akshay S. Desai, Jim Gong, Martin Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor Shi, Scott D. Solomon, Karl Swedberg, Michael R. Zile
Vydáno 2013Artigo -
17
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure Autor John J.V. McMurray, Milton Packer, Akshay S. Desai, Jianjian Gong, Martin Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor Shi, Scott D. Solomon, Karl Swedberg, Michael R. Zile
Vydáno 2014Artigo -
18
Renal effects of the angiotensin receptor neprilysin inhibitor <scp>LCZ696</scp> in patients with heart failure and preserved ejection fraction Autor Adriaan A. Voors, Mauro Gori, Licette C.Y. Liu, Brian Claggett, Michael R. Zile, Burkert Pieske, John J.V. McMurray, Milton Packer, Victor Shi, Martin Lefkowitz, Scott D. Solomon
Vydáno 2015Artigo -
19
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction Autor Michael R. Zile, Pardeep S. Jhund, Catalin F. Baicu, Brian Claggett, Burkert Pieske, Adriaan A. Voors, Margaret F. Prescott, Victor Shi, Martin Lefkowitz, John J.V. McMurray, Scott D. Solomon
Vydáno 2016Artigo -
20
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF Autor Michael R. Zile, Eileen O’Meara, Brian Claggett, Margaret F. Prescott, Scott D. Solomon, Karl Swedberg, Milton Packer, John J.V. McMurray, Victor Shi, Martin Lefkowitz, Jean L. Rouleau
Vydáno 2019Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Cardiology
Heart failure
Blood pressure
Ejection fraction
Valsartan
Sacubitril
Sacubitril, Valsartan
Angiotensin-converting enzyme
Enalapril
Confidence interval
Hazard ratio
Randomized controlled trial
Endocrinology
Clinical endpoint
Heart failure with preserved ejection fraction
Natriuretic peptide
ACE inhibitor
Chemistry
Biochemistry
Clinical trial
Enzyme
Neprilysin
Angiotensin II
Randomization
Renal function
Angiotensin receptor
Intensive care medicine
Myocardial infarction